Cargando…

Clinical Bioequivalence of Wixela Inhub and Advair Diskus in Adults With Asthma

Background: Wixela(®) Inhub(®) is a dry powder inhaler approved as a generic equivalent to Advair(®) Diskus(®) (fluticasone propionate [FP]/salmeterol fixed-dose combination) for patients with asthma or chronic obstructive pulmonary disease (COPD). This study aimed at confirming the local (lung) the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ng, Dik, Kerwin, Edward M., White, Martha V., Miller, S. David, Haughie, Scott, Ward, Jonathan K., Allan, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133441/ https://www.ncbi.nlm.nih.gov/pubmed/31634023 http://dx.doi.org/10.1089/jamp.2019.1547

Ejemplares similares

Equivalent Systemic Exposure to Fluticasone Propionate/Salmeterol Following Single Inhaled Doses from Advair Diskus and Wixela Inhub: Results of Three Pharmacokinetic Bioequivalence Studies
por: Haughie, Scott, et al.
Publicado: (2020)

Wixela Inhub: Dosing Performance In Vitro and Inhaled Flow Rates in Healthy Subjects and Patients Compared with Advair Diskus
por: Cooper, Andrew, et al.
Publicado: (2020)

Wixela Inhub: A Generic Equivalent Treatment Option for Patients with Asthma or COPD
por: Donohue, James F., et al.
Publicado: (2020)

Usability and Robustness of the Wixela Inhub Dry Powder Inhaler
por: Allan, Richard, et al.
Publicado: (2021)

Between‐Batch Pharmacokinetic Variability Inflates Type I Error Rate in Conventional Bioequivalence Trials: A Randomized Advair Diskus Clinical Trial
por: Burmeister Getz, E, et al.
Publicado: (2016)

In Vitro Performance of the Wixela Inhub Inhaler Using Severe Chronic Obstructive Pulmonary Disease Patient Inhalation Profiles
por: Shepherd, Thomas, et al.
Publicado: (2022)

A nurse‐led intervention study: Promoting compliance with Diskus Inhaler use in asthma patients
por: Mac Hale, Elaine, et al.
Publicado: (2014)

Skills in handling Turbuhaler, Diskus in the west of China
por: Wei, Wei, et al.
Publicado: (2023)

Comparison of inhalation technique with the Diskus and Autohaler in asthmatic children at home
por: van der Kolk, Annelies, et al.
Publicado: (2021)

The Role of ICS/LABA Fixed-Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate-Salmeterol Device
por: Tashkin, Donald P., et al.
Publicado: (2021)

The Diskus™: a review of its position among dry powder inhaler devices
por: Chrystyn, H
Publicado: (2007)

Skills in Handling Turbuhaler, Diskus, and Pressurized Metered-Dose Inhaler in Korean Asthmatic Patients
por: Lee, Sang Min, et al.
Publicado: (2011)

Performance of Multiple-Batch Approaches to Pharmacokinetic Bioequivalence Testing for Orally Inhaled Drug Products with Batch-to-Batch Variability
por: Burmeister Getz, Elise, et al.
Publicado: (2021)

Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler(®) in Comparison with Diskus(®) and Turbohaler(®) Dry Powder Inhalers
por: Buttini, Francesca, et al.
Publicado: (2016)

Pharmacokinetics of Salmeterol and Fluticasone Propionate Delivered in Combination via Easyhaler and Diskus Dry Powder Inhalers in Healthy Subjects
por: Kirjavainen, Merja, et al.
Publicado: (2018)

Between-Batch Bioequivalence (BBE): a Statistical Test to Evaluate In Vitro Bioequivalence Considering the Between-Batch Variability
por: Bodin, Jonathan, et al.
Publicado: (2020)

Bioequivalence: tried and tested
por: Schall, Robert, et al.
Publicado: (2010)

Bioequivalence studies in Morocco
por: Zaoui, Sanaa, et al.
Publicado: (2020)

Bioequivalence data analysis
por: Park, Gowooni, et al.
Publicado: (2020)

Investigating the relationship between peak inspiratory flow rate and volume of inhalation from a Diskus™ Inhaler and baseline spirometric parameters: a cross-sectional study
por: Seheult, Jansen N, et al.
Publicado: (2014)

Evaluation of pharmacokinetics and safety with bioequivalence of Amlodipine in healthy Chinese volunteers: Bioequivalence Study Findings
por: Wang, Tongtong, et al.
Publicado: (2020)

Reply letter to “Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial”
por: Hadigal, Sanjay, et al.
Publicado: (2022)

Reply letter to “Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018–2019 and 2019–2020 calculated using a retrospective test-negative design”
por: Hadigal, Sanjay, et al.
Publicado: (2023)

Allicin Bioavailability and Bioequivalence from Garlic Supplements and Garlic Foods
por: Lawson, Larry D., et al.
Publicado: (2018)

Bioequivalence assessment of two formulations of ibuprofen
por: Al-Talla, Zeyad A, et al.
Publicado: (2011)

Pharmacokinetics and Bioequivalence Evaluation of Cyclobenzaprine Tablets
por: Brioschi, Tatiane Maria de Lima Souza, et al.
Publicado: (2013)

Focus on biosimilar etanercept – bioequivalence and interchangeability
por: Cantini, Fabrizio, et al.
Publicado: (2018)

The Case for Standardizing the Appearance of Bioequivalent Medications
por: Engelberg, Alfred B.
Publicado: (2011)

Safety and Efficacy of Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a Metered-Dose-Inhaler Compared with Fluticasone Propionate/Salmeterol Diskus in Patients with Chronic Obstructive Pulmonary Disease
por: Koser, Andras, et al.
Publicado: (2010)

Single‐Dose Bioequivalence of Two Mini Nicotine Lozenge Formulations
por: Rasmussen, Scott C., et al.
Publicado: (2017)

Current Bioequivalence Study Designs in South Korea: A Comprehensive Analysis of Bioequivalence Study Reports Between 2013 and 2019
por: Huh, Ki Young, et al.
Publicado: (2021)

Evaluation of Pharmacokinetics and Safety with Bioequivalence of Ibuprofen Sustained-Release Capsules of Two Formulations, in Chinese Healthy Volunteers: Bioequivalence Study
por: Huang, Chunqi, et al.
Publicado: (2023)

Bioequivalence study of cyclosporine in renal transplant recipients
por: Gautam, Gagan
Publicado: (2007)

Sample Size Determination for Individual Bioequivalence Inference
por: Chiang, Chieh, et al.
Publicado: (2014)

Evaluation of Bioequivalence of Two Oral Formulations of Olanzapine
por: Singhal, R., et al.
Publicado: (2011)

Update on the safety and bioequivalence of biosimilars – focus on enoxaparin
por: Jeske, Walter, et al.
Publicado: (2013)

Bioequivalence data analysis for the case of separate hospitalization
por: Bae, Kyun-Seop, et al.
Publicado: (2017)

An In Vitro–In Vivo Simulation Approach for the Prediction of Bioequivalence
por: Vlachou, Marilena, et al.
Publicado: (2021)

Evaluation of the Bioequivalence of Acarbose in Healthy Chinese People
por: Chen, Yan, et al.
Publicado: (2021)

Predictive Potential of C(max) Bioequivalence in Pilot Bioavailability/Bioequivalence Studies, through the Alternative ƒ(2) Similarity Factor Method
por: Henriques, Sara Carolina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_076qcijb5ar28k7al81tevgku6